Simcere Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Simcere Pharmaceutical Group has a total shareholder equity of CN¥7.2B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are CN¥10.9B and CN¥3.6B respectively. Simcere Pharmaceutical Group's EBIT is CN¥710.8M making its interest coverage ratio -34.9. It has cash and short-term investments of CN¥2.0B.
Key information
16.9%
Debt to equity ratio
CN¥1.22b
Debt
| Interest coverage ratio | -34.9x |
| Cash | CN¥2.02b |
| Equity | CN¥7.22b |
| Total liabilities | CN¥3.63b |
| Total assets | CN¥10.85b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SMHG.F's short term assets (CN¥5.6B) exceed its short term liabilities (CN¥2.7B).
Long Term Liabilities: SMHG.F's short term assets (CN¥5.6B) exceed its long term liabilities (CN¥945.0M).
Debt to Equity History and Analysis
Debt Level: SMHG.F has more cash than its total debt.
Reducing Debt: SMHG.F's debt to equity ratio has reduced from 144.5% to 16.9% over the past 5 years.
Debt Coverage: SMHG.F's debt is not well covered by operating cash flow (12.4%).
Interest Coverage: SMHG.F earns more interest than it pays, so coverage of interest payments is not a concern.